-
More than three years after new guidelines rejected routine annual mammograms for most women, women in all age groups continue to get yearly screenings, new research indicates.1
-
The National Institute of Allergy and Infectious Diseases (NIAID) is halting the administration of injections in the clinical trial of an investigational HIV vaccine regimen after a scheduled interim review data indicated the regimen did not prevent HIV infection, nor did it reduce viral load among vaccine recipients who became infected with HIV.
-
Five years after Australia launched a national human papillomavirus (HPV) vaccination program in young women, data indicates that genital wart cases have dropped not only among women, but heterosexual men as well.1
-
The U.S. Preventive Services Task Force (USPSTF) has just released its final recommendation statement on screening for HIV, and it recommends that clinicians screen all people ages 15 to 65, as well as younger adolescents and older adults who are at an increased risk for HIV infection, such as those who engage in unprotected vaginal or anal intercourse, use injection drugs, or are men who have sex with men.1
-
Results of a current study of women using the contraceptive injection depot medroxyprogesterone acetate (DMPA, Depo-Provera, Pfizer, New York City; Medroxyprogesterone Acetate Injectable Suspension USP, Teva Pharmaceuticals USA, North Wales, PA) indicate a modest increase in fracture risk compared with women using other contraceptive methods; however, the increased risk of fracture preceded the start of method use, analysis shows.
-
A new campaign launched Valentines Day 2013 is stressing the importance of preconception health for every young woman, not just those who are planning a pregnancy.
-
Bivalent and quadrivalent human papillomavirus (HPV) vaccines are safe and effective, with the potential to prevent a large burden of cancers and diseases.
-
-
New national statistics show that about one in nine (11% or 5.8 million) women ages 15 to 44 had ever used emergency contraception (EC) in 2006-2010, up from 4.2% in 2002.1 Young adult women ages 20-24 were the most likely to have ever used EC about one in four (23%) indicated they had utilized the method.
-
While use of intrauterine devices (IUDs) represents a highly effective form of birth control, many women still are not getting proper information about it, results of a new survey indicate.1 Only one-fifth of the women surveyed knew that intrauterine devices were more effective in preventing pregnancy than oral contraception, while only 29% knew that IUDs are cheaper over time than pills.
